51218-98-5

Basic information

• Product Name: 2-isopropoxyethyl 4-methylbenzenesulfonate
• Synonyms: 2-isopropoxyethyl 4-methylbenzenesulfonate
• CAS NO: 51218-98-5
• Molecular Weight: 258.339
• Mol File: 51218-98-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-isopropoxyethyl 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-isopropoxyethyl 4-methylbenzenesulfonate(51218-98-5)
• EPA Substance Registry System: 2-isopropoxyethyl 4-methylbenzenesulfonate(51218-98-5)

Safety Data

• Hazardous Substances Data: 51218-98-5(Hazardous Substances Data)

Upstream product

• 109-59-1 2-(1-methylethoxy)-ethanol 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 246853-87-2 4-(2-isopropoxy)ethoxybenzoic acid 
• 1236766-09-8 3-[4-(Cyclopropylmethoxy)phenyl]-2-{[2-(1-methylethoxy)ethyl]sulfanyl}-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one 
• 852030-66-1 2-amino-9-(2-isopropoxy-ethyl)-8-(3,4,5-trimethoxy-phenylsulfanyl)adenine 
• 54645-59-9 5-(N,N-dibenzylglycyl)-2-(2-isopropoxyethoxy)-benzamide 

Relevant articles and documents

2-AMINO-QUINOLINE DERIVATIVES

Described herein are 2-amino-quinoline derivatives that are agonists of toll-like receptors 7 and 8 (TLR7/8), pharmaceutical compositions, and methods of use of the compounds and compositions to treat various diseases, such as viral, cancer, and allergic diseases, in need thereof by administering a therapeutically effective amount of a 2-amino-quinoline derivative.

Glucopyranosyl derivative and application thereof in medicines

The invention relates to a glucopyranosyl derivative used as a sodium-dependent glucose transporter (SGLT) inhibitor, a medicinal composition containing the derivative, and an application of the derivative and the medicinal composition in medicines, and especially relates to the glucopyranosyl derivative represented by formula (I) or a pharmaceutically acceptable salt or all stereoisomers thereof, or the medicinal composition containing the derivative, and a use of the derivative and the medicinal composition in the preparation of medicines for treating diabetes and diabetes related diseases.

Pyrazole glucokinase activators

Disclosed herein are pyrazole glucokinase activators of the formula (I) useful for the treatment of metabolic diseases and disorders, preferably diabetes mellitus.